These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30075743)

  • 1. Tumor vasculature: a sally port for inhibiting cancer cell spreading.
    Qian CN; Pezzella F
    Cancer Commun (Lond); 2018 Aug; 38(1):52. PubMed ID: 30075743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
    Raza A; Franklin MJ; Dudek AZ
    Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation.
    Qian CN; Tan MH; Yang JP; Cao Y
    Chin J Cancer; 2016 Jan; 35():10. PubMed ID: 26747273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pericytes: a double-edged sword in cancer therapy.
    Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
    Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis as a hallmark of solid tumors - clinical perspectives.
    Majidpoor J; Mortezaee K
    Cell Oncol (Dordr); 2021 Aug; 44(4):715-737. PubMed ID: 33835425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pericytes: gatekeepers in tumour cell metastasis?
    Gerhardt H; Semb H
    J Mol Med (Berl); 2008 Feb; 86(2):135-44. PubMed ID: 17891366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of pericytes in angiogenesis: focus on cancer angiogenesis and anti-angiogenic therapy.
    Chen Z; Xu XH; Hu J
    Neoplasma; 2016; 63(2):173-82. PubMed ID: 26774138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What tumor vessels can tell us.
    Lee S
    Pigment Cell Melanoma Res; 2010 Jun; 23(3):309-11. PubMed ID: 20403121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
    Eberhard A; Kahlert S; Goede V; Hemmerlein B; Plate KH; Augustin HG
    Cancer Res; 2000 Mar; 60(5):1388-93. PubMed ID: 10728704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the tumor stroma in cancer therapy.
    Anton K; Glod J
    Curr Pharm Biotechnol; 2009 Feb; 10(2):185-91. PubMed ID: 19199950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.
    Gee MS; Procopio WN; Makonnen S; Feldman MD; Yeilding NM; Lee WM
    Am J Pathol; 2003 Jan; 162(1):183-93. PubMed ID: 12507901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of tumor neovascularization.
    Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ishikura H
    Vasc Health Risk Manag; 2005; 1(4):277-90. PubMed ID: 17315600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
    Leuci V; Maione F; Rotolo R; Giraudo E; Sassi F; Migliardi G; Todorovic M; Gammaitoni L; Mesiano G; Giraudo L; Luraghi P; Leone F; Bussolino F; Grignani G; Aglietta M; Trusolino L; Bertotti A; Sangiolo D
    J Transl Med; 2016 May; 14(1):119. PubMed ID: 27149858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of the pericyte during angiogenesis and its role in cancer and diabetic retinopathy.
    Hall AP
    Toxicol Pathol; 2006; 34(6):763-75. PubMed ID: 17162534
    [No Abstract]   [Full Text] [Related]  

  • 16. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
    Leite de Oliveira R; Hamm A; Mazzone M
    Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation.
    Nguyen NQ; Castermans K; Berndt S; Herkenne S; Tabruyn SP; Blacher S; Lion M; Noel A; Martial JA; Struman I
    PLoS One; 2011; 6(11):e27318. PubMed ID: 22087289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels.
    Iivanainen E; Lauttia S; Zhang N; Tvorogov D; Kulmala J; Grenman R; Salven P; Elenius K
    Microvasc Res; 2009 Dec; 78(3):278-85. PubMed ID: 19596357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological features of vessel co-option versus sprouting angiogenesis.
    Latacz E; Caspani E; Barnhill R; Lugassy C; Verhoef C; Grünhagen D; Van Laere S; Fernández Moro C; Gerling M; Dirix M; Dirix LY; Vermeulen PB
    Angiogenesis; 2020 Feb; 23(1):43-54. PubMed ID: 31655928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.